title: The diagnosis and treatment of elderly patients with acute exacerbation of chronic obstructive pulmonary disease and chronic bronchitis.
abstract: The syndrome of chronic obstructive pulmonary disease (COPD) consists of chronic bronchitis (CB), bronchiectasis, emphysema, and reversible airway disease that combine uniquely in an individual patient. Older patients are at risk for COPD and its components--emphysema, CB, and bronchiectasis. Bacterial and viral infections play a role in acute exacerbations of COPD (AECOPD) and in acute exacerbations of CB (AECB) without features of COPD. Older patients are at risk for resistant bacterial organisms during their episodes of AECOPD and AECB. Organisms include the more-common bacteria implicated in AECOPD/AECB such as Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae. Less-common nonenteric, gram-negative organisms including Pseudomonas aeruginosa, gram-positive organisms including Staphylococcus aureus, and strains of nontuberculosis Mycobacteria are more often seen in AECOPD/AECB episodes involving elderly patients with frequent episodes of CB or those with bronchiectasis. Risk-stratified antibiotic treatment guidelines appear useful for purulent episodes of AECOPD and episodes of AECB. These guidelines have not been prospectively validated for the general population and especially not for the elderly population. Using a risk-stratification approach for elderly patients, first-line antibiotics (e.g., amoxicillin, ampicillin, pivampicillin, trimethoprim/sulfamethoxazole, and doxycycline), with a more-limited spectrum of antibacterial coverage, are used in patients who are likely to have a low probability of resistant organisms during AECOPD/AECB. Second-line antibiotics (e.g., amoxicillin/clavulanic acid, second- or third-generation cephalosporins, and respiratory fluoroquinolones) with a broader spectrum of coverage are reserved for patients with significant risk factors for resistant organisms and those who have failed initial antibiotic treatment.
authors.affiliation: Division of Pulmonary, Critical Care and Sleep Medicine, School of Medicine University of California at Davis, Sacramento, California, USA. tealbertson@ucdavis.edu
authors.forename: Timothy E
authors.initials: TE
authors.lastname: Albertson
authors.forename: Samuel
authors.initials: S
authors.lastname: Louie
authors.forename: Andrew L
authors.initials: AL
authors.lastname: Chan
mesh_terms: D000208:Acute Disease; D000367:Age Factors; D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology; D001987:Bronchiectasis / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy; D029481:Bronchitis, Chronic / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy* / Q000453:epidemiology; D006801:Humans; D029424:Pulmonary Disease, Chronic Obstructive / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy* / Q000453:epidemiology; D012141:Respiratory Tract Infections / Q000175:diagnosis* / Q000188:drug therapy* / Q000453:epidemiology / Q000209:etiology
chemical_list: D000900:Anti-Bacterial Agents
references.citation: Thorax. 2008 May;63(5):415-22
references.pmid: 18234905
references.citation: Annu Rev Pathol. 2009;4:435-59
references.pmid: 18954287
references.citation: Int J Chron Obstruct Pulmon Dis. 2009;4:45-53
references.pmid: 19436696
references.citation: Chest. 2003 May;123(5):1684-92
references.pmid: 12740290
references.citation: Curr Opin Pulm Med. 2008 Nov;14(6):595-9
references.pmid: 18812838
references.citation: Chest. 2000 Feb;117(2 Suppl):1S-4S
references.pmid: 10673465
references.citation: Can Fam Physician. 2009 Jan;55(1):60-7
references.pmid: 19155372
references.citation: Chest. 2003 Mar;123(3):772-7
references.pmid: 12628877
references.citation: Clin Infect Dis. 2001 May 15;32 Suppl 2:S81-93
references.pmid: 11320449
references.citation: Drugs Aging. 2002;19(10):761-75
references.pmid: 12390053
references.citation: Lancet. 2007 Sep 1;370(9589):741-50
references.pmid: 17765523
references.citation: Ageing Res Rev. 2004 Jan;3(1):55-67
references.pmid: 15163102
references.citation: Thorax. 2006 Oct;61(10):843-8
references.pmid: 16928716
references.citation: Value Health. 2001 Sep-Oct;4(5):370-5
references.pmid: 11705127
references.citation: Proc Am Thorac Soc. 2005;2(5):433-9
references.pmid: 16322596
references.citation: Clin Ther. 1999 Mar;21(3):576-91
references.pmid: 10321424
references.citation: J Int Med Res. 2001 Jul-Aug;29(4):314-28
references.pmid: 11675905
references.citation: Eur Respir J. 2005 Jun;25(6):1001-10
references.pmid: 15929954
references.citation: Pulm Pharmacol Ther. 2006;19(5):311-9
references.pmid: 16260162
references.citation: Clin Microbiol Rev. 2001 Apr;14(2):336-63
references.pmid: 11292642
references.citation: Thorax. 2002 Feb;57(2):137-41
references.pmid: 11828043
references.citation: Int J Antimicrob Agents. 2007 Jan;29(1):56-61
references.pmid: 17189096
references.citation: Int J Antimicrob Agents. 2007 Jul;30(1):52-9
references.pmid: 17512704
references.citation: Ann Intern Med. 1987 Feb;106(2):196-204
references.pmid: 3492164
references.citation: Fam Pract. 2007 Sep;24(4):317-22
references.pmid: 17602175
references.citation: Clin Ther. 2006 Aug;28(8):1175-1180
references.pmid: 16982294
references.citation: Value Health. 2008 Jul-Aug;11(4):628-36
references.pmid: 18194402
references.citation: Respir Med. 2003 Mar;97(3):242-9
references.pmid: 12645831
references.citation: Cochrane Database Syst Rev. 2002;(4):CD003900
references.pmid: 12519615
references.citation: Clin Infect Dis. 2005 Jul 1;41(1):118-21
references.pmid: 15937772
references.citation: Int J Chron Obstruct Pulmon Dis. 2008;3(4):515-20
references.pmid: 19281070
references.citation: Chest. 2009 Apr;135(4):975-982
references.pmid: 19017866
references.citation: Chest. 2008 Mar;133(3):756-66
references.pmid: 18321904
references.citation: Am J Respir Crit Care Med. 1998 May;157(5 Pt 1):1498-505
references.pmid: 9603129
references.citation: Am J Respir Crit Care Med. 2004 Aug 15;170(4):400-7
references.pmid: 15130905
references.citation: Chest. 1998 Jun;113(6):1542-8
references.pmid: 9631791
references.citation: Int J Antimicrob Agents. 2004 Feb;23(2):129-37
references.pmid: 15013037
references.citation: Chest. 2000 May;117(5 Suppl 2):398S-401S
references.pmid: 10843984
references.citation: Can Respir J. 2008 Jan-Feb;15 Suppl A:1A-8A
references.pmid: 18292855
references.citation: N Engl J Med. 2002 Aug 15;347(7):465-71
references.pmid: 12181400
references.citation: Eur Respir J. 2007 Jun;29(6):1127-37
references.pmid: 17301097
references.citation: Drugs Aging. 2007;24(7):555-72
references.pmid: 17658907
references.citation: Swiss Med Wkly. 2003 May 3;133(17-18):247-57
references.pmid: 12833195
references.citation: Curr Opin Infect Dis. 2006 Jun;19(3):225-30
references.pmid: 16645482
references.citation: Drugs Aging. 2004;21(13):851-64
references.pmid: 15493950
references.citation: Lancet Infect Dis. 2006 Oct;6(10):629-40
references.pmid: 17008172
references.citation: Proc Am Thorac Soc. 2007 Oct 1;4(7):554-64
references.pmid: 17878469
references.citation: Am J Manag Care. 2004 Oct;10(10):689-96
references.pmid: 15521160
references.citation: Chest. 2008 Oct;134(4):815-823
references.pmid: 18842914
references.citation: Clin Infect Dis. 2005 Aug 15;41 Suppl 4:S234-8
references.pmid: 16032558
references.citation: Respir Med. 2007 Jun;101(6):1097-105
references.pmid: 17239575
references.citation: J Antimicrob Chemother. 2008 Sep;62(3):442-50
references.pmid: 18467303
references.citation: Chest. 2004 Mar;125(3):953-64
references.pmid: 15006954
references.citation: Ther Adv Respir Dis. 2007 Oct;1(1):61-76
references.pmid: 19124348
references.citation: Drugs Aging. 2009;26(6):447-56
references.pmid: 19591519
references.citation: Chest. 2000 May;117(5 Suppl 2):380S-5S
references.pmid: 10843981
references.citation: JAMA. 2003 Nov 5;290(17):2301-12
references.pmid: 14600189
references.citation: Can Respir J. 2000 Nov-Dec;7(6):466-71
references.pmid: 11121091
references.citation: Respir Med. 2006 Sep;100(9):1504-11
references.pmid: 16504492
references.citation: J Chemother. 2002 Dec;14(6):597-608
references.pmid: 12583552
references.citation: Clin Ther. 2001 Jan;23(1):72-86
references.pmid: 11219481
references.citation: Pulm Pharmacol Ther. 2006;19(5):361-9
references.pmid: 16289762
references.citation: Chest. 2007 Aug;132(2):447-55
references.pmid: 17573508
references.citation: Can Respir J. 2003 Jul-Aug;10 Suppl B:3B-32B
references.pmid: 12944998
references.citation: Int J Chron Obstruct Pulmon Dis. 2008;3(3):331-50
references.pmid: 18990961
references.citation: Eur Respir J. 2006 Feb;27(2):397-412
references.pmid: 16452599
references.citation: Chest. 2009 Jan;135(1):173-180
references.pmid: 19136405
references.citation: JAMA. 1995 Mar 22-29;273(12):957-60
references.pmid: 7884956
references.citation: South Med J. 2009 Mar;102(3):277-82
references.pmid: 19204646
references.citation: Respir Med. 2004 Feb;98(2):99-107
references.pmid: 14971871
references.citation: Cochrane Database Syst Rev. 2006 Apr 19;(2):CD004403
references.pmid: 16625602